Bcl-2, BTK, and PI3 Inhibitors Among Highlights Presented at ASH 2015

Jeff Sharman, MD Medical Director of Hematology Research for US Oncology discusses ASH 2015 highlights as Bcl-2, BTK, and PI3 Inhibitors